|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM353698067 |
| 003 |
DE-627 |
| 005 |
20231226060615.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2023 xx |||||o 00| ||jpn c |
| 024 |
7 |
|
|a 10.14989/ActaUrolJap_69_2_59
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1178.xml
|
| 035 |
|
|
|a (DE-627)NLM353698067
|
| 035 |
|
|
|a (NLM)36863873
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a jpn
|
| 100 |
1 |
|
|a Kokubun, Hidetoshi
|e verfasserin
|4 aut
|
| 245 |
1 |
2 |
|a A Case of m0CRPC after Hormone Therapy for Pelvic Lymph Node Metastasis in which Salvage RARP was Effective
|
| 264 |
|
1 |
|c 2023
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 06.03.2023
|
| 500 |
|
|
|a Date Revised 06.03.2023
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a The patient was a 63-year-old man with biopsy Gleason score of 4＋5 prostate cancer with an initial prostate specific antigen level of (PSA) 51.2ng/ml. On imaging examination, extracapsular invasion, rectal invasion, and pararectal lymph node metastasis were found (cT4N1M0). After 4 years of androgen deprivation therapy, PSA decreased to 0.631ng/ml, and then increased gradually to1.2ng/ml. Computed tomographic scan showed that the primary tumor had shrunk and lymph node metastasis had disappeared; so salvage robot-assisted resection of the prostate (RARP) was performed for non-metastatic castration-resistant prostate cancer (m0CRPC). Since PSA decreased to an undetactable level, hormone therapy was terminated at 1 year. The patient remained recurrence-free for 3 years after surgery. RARP may be effective for m0CRPC, enabling discontinuation of androgen deprivation therapy
|
| 650 |
|
4 |
|a Case Reports
|
| 650 |
|
4 |
|a English Abstract
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Prostate-Specific Antigen
|2 NLM
|
| 650 |
|
7 |
|a EC 3.4.21.77
|2 NLM
|
| 650 |
|
7 |
|a Androgen Antagonists
|2 NLM
|
| 650 |
|
7 |
|a Androgens
|2 NLM
|
| 700 |
1 |
|
|a Kubota, Masashi
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Kambe, Takanari
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Mine, Yuta
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Hagimoto, Hiroki
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yamaguchi, Ritsuki
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Murata, Shiori
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Makita, Noriyuki
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Hattori, Yuto
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Abe, Yohei
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Tsutsumi, Naofumi
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Yamasaki, Toshinari
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Inoue, Koji
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Kawakita, Mutsushi
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Hinyokika kiyo. Acta urologica Japonica
|d 1962
|g 69(2023), 2 vom: 14. Feb., Seite 59-62
|w (DE-627)NLM012631779
|x 0018-1994
|7 nnns
|
| 773 |
1 |
8 |
|g volume:69
|g year:2023
|g number:2
|g day:14
|g month:02
|g pages:59-62
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.14989/ActaUrolJap_69_2_59
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_2001
|
| 912 |
|
|
|a GBV_ILN_2003
|
| 912 |
|
|
|a GBV_ILN_2005
|
| 912 |
|
|
|a GBV_ILN_2006
|
| 912 |
|
|
|a GBV_ILN_2008
|
| 912 |
|
|
|a GBV_ILN_2010
|
| 912 |
|
|
|a GBV_ILN_2012
|
| 912 |
|
|
|a GBV_ILN_2018
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 69
|j 2023
|e 2
|b 14
|c 02
|h 59-62
|